TB 500: 25 mg weekly, often used systemically
Refrigeration recommended after opening

(4)(semaglutide)pH7.4 (semaglutide): 4.8 mg/ml ()() 8 mM(1.42 mg/ml)18.5 mg/ml 15 mM(2.67 mg/ml)17.5 mg/ml 20 mM (3.56 mg/ml)17.0 mg/ml 20 mM (3.56 mg/ml)7.60 mg/ml (HCl)pH7.4 (NaOH)pH7.4 (WFI)A total of four (4) semaglutide formulations were prepared, with various phosphate concentrations at pH 7.4, and the following composition: Semaglutide: 4.8 mg/ml Phosphate (buffer), and propylene glycol or sodium chloride as one of the following combinations of isotonic agents (the concentration of isotonic agent is adjusted according to the phosphate concentration to obtain an approximate isotonic formula): 8 mM phosphate (added as 1.42 mg/ml disodium hydrogen phosphate dihydrate) and 18.5 mg/ml propylene glycol 15 mM phosphate (added as 2.67 mg/ml disodium hydrogen phosphate dihydrate) and 17.5 mg/ml propylene glycol 20 mM phosphate (added as 3.56 mg/ml disodium hydrogen phosphate dihydrate) and 17.0 mg/ml propylene glycol 20 mM phosphate (added as 3.56 mg/ml disodium hydrogen phosphate dihydrate) and 7.60 mg/ml sodium chloride Hydrochloric acid (HCl), add as needed to obtain a pH of 7.4 Sodium hydroxide (NaOH), add as needed to obtain a pH of 7.4 Water for injection (WFI) is used as a solvent

At the same time, our preclinical safety evaluation studies showed that BPC157 was well tolerated and did not demonstrate any serious toxic effects in mice, rats, rabbits, or dogs (Xu et al., 2020)
Many patients report reduced inflammation and early improvement in soreness within the first 5 to 14 days